相关实验视频

Updated: May 29, 2025

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

通过Epigallocatechin gallate进行Aurora kinase B调制的结构性表征:从对接和动力学模拟的见解

Prashanth S Javali¹, Kavitha Thirumurugan¹

¹Structural Biology Lab, Pearl Research Park, School of Biosciences & Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.

Journal of molecular graphics & modelling

|February 6, 2025

概括

绿茶中的表甲基-3-酸盐 (EGCG) 可能抑制光激酶B (AURKB),这是一个癌症标. 分子模拟表明EGCG与AURKB结合,改变其结构,从而可能提高癌症治疗的有效性.

科学领域:

生物化学生化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

极光激酶B (AURKB) 对于细胞分裂至关重要,也是癌症治疗的目标.
合成的AURKB抑制剂往往缺乏特异性;像EGCG这样的天然化合物提供了潜力.
绿茶中的甲基因EGCG具有抗癌性质,并抑制多种激酶.

研究的目的:

为了研究epigallocatechin-3-gallate (EGCG) 作为光激酶B (AURKB) 抑制剂的潜力.
阐明EGCG与AURKB结合时的分子相互作用和形状变化.
评估EGCG在增强抗癌疗法疗效方面的潜力.

主要方法:

在EGCG的药理动力学和药理动力学的In silico预测.
使用AutoDock将EGCG与AURKB的分子对接.
使用GROMACS.使用AURKB-EGCG复合物的100ns分子动力学模拟.
自由能量表面分析和MMPBSA用于具有约束力的稳定性评估.

主要成果:

EGCG表现为稳定且自发地与AURKB结合.
结合EGCG诱导了AURKB DFG图案的显著构造变化,将其转移到DFG-out状态.
观察到蛋白质二次结构的变化,有助于形成稳定的复合体.

结论:

通过诱导AURKB.的构造变化,EGCG作为ATP竞争性抑制剂起作用.
这些发现表明EGCG作为治疗剂的潜力,可以降低质瘤细胞对癌症药物的抵抗力.
EGCG与AURKB的互动为开发新的,更安全的抗癌策略提供了见解.

关键词:

结合ATP与ATP的结合方式这就是AURKBB.德国联邦政府的图案是DFG的图案.甲基甲基酸盐 (EGCG) 是一种甲基酸盐.这就是MMPBSA.分子动力学分子动力学

更多相关视频

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

相关概念视频

Allosteric Regulation

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...